Comparison of Testosterone Replacement Therapy Medications in the Treatment of Hypogonadism
| Autor: | Karlen Beth Luthy, Aaron Cook, Christopher Ty Williams, Donna Freeborn |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Advanced and Specialized Nursing
Gynecology Pediatrics medicine.medical_specialty 030219 obstetrics & reproductive medicine business.industry Dose interval 030232 urology & nephrology Treatment options Individualized treatment Testosterone (patch) 03 medical and health sciences 0302 clinical medicine Medicine Testosterone replacement business Patient compliance |
| Zdroj: | The Journal for Nurse Practitioners. 13:241-249 |
| ISSN: | 1555-4155 |
| DOI: | 10.1016/j.nurpra.2016.11.016 |
| Popis: | Testosterone replacement therapy (TRT) is 1 treatment option for men with hypogonadism. When TRT is prescribed, effectiveness, patient compliance, cost, and potential side effects should be considered and used to develop an individualized treatment plan. Depo-Testosterone (Pfizer Inc, New York, NY, USA) is the most cost-efficient TRT option and is only administered every 2 weeks, which may improve patient compliance, although the dose interval can be adjusted to once per week. Androderm is the most efficacious TRT medication, with up to 92% of patients reaching normal testosterone levels. Testim (Endo Pharmaceuticals Inc, Malvern, PA, USA) and Vogelxo (Upsher-Smith Laboratories Inc, Maple Grove, MN, USA) have the fewest reported side effects. We recommend Depo-Testosterone as a first-line treatment option. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect